|
HSD17B12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5612299999912E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77715999999384E-05 |
| Normal-vs-Stage2 |
5.455600E-02 |
| Normal-vs-Stage3 |
1.076170E-02 |
| Normal-vs-Stage4 |
2.07299999999133E-05 |
| Stage1-vs-Stage2 |
4.696800E-01 |
| Stage1-vs-Stage3 |
6.531400E-01 |
| Stage1-vs-Stage4 |
1.462770E-01 |
| Stage2-vs-Stage3 |
7.883800E-01 |
| Stage2-vs-Stage4 |
8.379900E-02 |
| Stage3-vs-Stage4 |
1.092010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30700000000339E-05 |
| Normal-vs-AfricanAmerican |
3.7774000000157E-06 |
| Normal-vs-Asian |
4.121900E-02 |
| Caucasian-vs-AfricanAmerican |
1.639440E-01 |
| Caucasian-vs-Asian |
8.898600E-01 |
| AfricanAmerican-vs-Asian |
6.955200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.4330999999539E-07 |
| Normal-vs-Female |
2.046500E-02 |
| Male-vs-Female |
2.304300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.162700E-04 |
| Normal-vs-Extreme_Weight |
4.49060000000667E-05 |
| Normal-vs-Obese |
5.432300E-04 |
| Normal-vs-Extreme_Obese |
6.798500E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.929400E-01 |
| Normal_Weight-vs-Obese |
7.919200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.871800E-01 |
| Extreme_Weight-vs-Obese |
7.632400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.800200E-01 |
| Obese-vs-Extreme_Obese |
7.731600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.408610E-01 |
| Normal-vs-Age(41-60Yrs) |
1.567220E-04 |
| Normal-vs-Age(61-80Yrs) |
4.24470000004451E-06 |
| Normal-vs-Age(81-100Yrs) |
2.787600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.190200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.929800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.700770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.260800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.903600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.552800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.65159999996079E-06 |
| Normal-VS-Type2 PRCC |
6.08619999999949E-05 |
| Normal-VS-KIRP CIMP |
3.033000E-01 |
| Normal-VS-Unclassified PRCC |
2.458100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.282800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.595000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.480600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.607600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.710800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.286200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.48529999996783E-06 |
| Normal-vs-N1 |
1.163790E-02 |
| Normal-vs-N2 |
1.428320E-02 |
| N0-vs-N1 |
2.326000E-01 |
| N0-vs-N2 |
9.242400E-01 |
| N1-vs-N2 |
5.077000E-01 |
|
|
